|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of operating lease assets | |||||
| Non-cash interest expense | |||||
| Equity-based compensation expense | |||||
| Equity issued in litigation settlement | |||||
| Deferred income taxes | |||||
| Loss (gain) on sale of assets | |||||
| Other | |||||
| Changes in operating assets and liabilities, net of effects of acquisitions | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Other current assets | |||||
| Other non-current assets | |||||
| Accounts payable and accrued liabilities | |||||
| Other current liabilities | |||||
| Lease liabilities | |||||
| Income taxes | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Additions to capital assets | |||||
| Investments in notes receivable | |||||
| Collection of notes receivable | |||||
| Proceeds from sale of assets | |||||
| Acquisition of businesses, net of cash acquired | |||||
| Purchases of intangible assets | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from issuance of common stock in private placement | |||||
| Proceeds from issuance of common stock in public offerings, net of underwriting discounts and commissions and offering expenses | |||||
| Proceeds from issuance of debt | |||||
| Repayments of debt | |||||
| Proceeds from finance leases | |||||
| Debt issuance costs | |||||
| Repayments of finance leases | |||||
| Proceeds from exercise of stock options | |||||
| Taxes withheld under equity-based compensation plans, net | |||||
| Repurchase of warrants | |||||
| Repurchase of common stock and warrants | |||||
| Payment of contingent consideration | |||||
| Distributions to non-controlling interests | |||||
| Net cash provided by (used in) financing activities | |||||
| Net (decrease) increase in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | |||||
| Cash, cash equivalents, and restricted cash at end of period | |||||
| Supplemental Cash Flow Information | |||||
| Interest paid on loans | |||||
| Income tax (refunds) payments, net | |||||
| Non-cash investing and financing activities | |||||
| Capital expenditures incurred but not yet paid | |||||
| Taxes withheld under equity-based compensation plans, net | |||||
| Debt instrument converted into share amount | |||||
| Conversion of convertible notes and accrued interest upon initial public offering | |||||
| Shares issued for share-settled debt | |||||
| Conversion of preferred units into Class A common stock upon initial public offering | |||||
| Beneficial conversion feature associated with conversion of preferred units upon initial public offering | |||||
| Non-controlling interest recognized upon initial consolidation of variable interest entities | |||||
| Issuance of shares in business acquisitions | |||||
| Issuance of shares for purchase of intangible assets | |||||
| Warrants issued with notes payable | |||||
Loading...
